These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5641302)

  • 21. Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study.
    Dibek Misirlioglu E; Guvenir H; Bahceci S; Haktanir Abul M; Can D; Usta Guc BE; Erkocoğlu M; Toyran M; Nacaroglu HT; Civelek E; Buyuktiryaki B; Ginis T; Orhan F; Kocabas CN
    J Allergy Clin Immunol Pract; 2017; 5(3):757-763. PubMed ID: 28351788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of Stevens-Johnson Syndrome at the University College Hospital, Ibadan.
    Onadeko BO
    West Afr Med J Niger Pract; 1970 Oct; 19(5):142-4. PubMed ID: 5491139
    [No Abstract]   [Full Text] [Related]  

  • 24. Stevens-Johnson syndrome. A review of 34 cases.
    Ting HC; Adam BA
    Int J Dermatol; 1985 Nov; 24(9):587-91. PubMed ID: 4066102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
    Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP
    Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse cutaneous drug reactions in a single quaternary referral hospital.
    Botelho LF; Porro AM; Enokihara MM; Tomimori J
    Int J Dermatol; 2016 Apr; 55(4):e198-203. PubMed ID: 26710962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stevens-Johnson syndrome and toxic epidermal necrolysis in Togo: the role of self-medication].
    Saka B; Kombaté K; Egbohou P; Mouhari-Toure A; Akakpo S; Boukari T; Tchangaï-Walla K; Pitché P
    Ann Dermatol Venereol; 2012 Jun; 139(6-7):486-7. PubMed ID: 22721483
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of the ocular findings in Stevens-Johnson syndrome patients from a tertiary ophthalmologic center].
    Franca MD; Lima JP; Freitas Dd; Cunha M; Gomes JA
    Arq Bras Oftalmol; 2009; 72(3):370-4. PubMed ID: 19668969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs.
    Ordoñez L; Salgueiro E; Jimeno FJ; Manso G
    Eur Rev Med Pharmacol Sci; 2015; 19(14):2732-7. PubMed ID: 26221907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens-Johnson syndrome associated with long-acting sulfonamides.
    Carroll OM; Bryan PA; Robinson RJ
    JAMA; 1966 Feb; 195(8):691-3. PubMed ID: 5951775
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions.
    Rzany B; Correia O; Kelly JP; Naldi L; Auquier A; Stern R
    Lancet; 1999 Jun; 353(9171):2190-4. PubMed ID: 10392983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of Stevens-Johnson syndrome at the University College Hospital, Ibadan.
    Onadeko BO
    West Afr Med J Niger Med Dent Pract; 1972 Jun; 21(3):78-80. PubMed ID: 4639174
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pluriorificial erosive ectodermosis (Stevens-Johnson Syndrome)].
    Landolt RF
    Praxis; 1968 Nov; 57(44):1534-8. PubMed ID: 5757105
    [No Abstract]   [Full Text] [Related]  

  • 34. Morbidity and mortality of mucocutaneous diseases in the pediatric population at a tertiary care center.
    Dore J; Salisbury RE
    J Burn Care Res; 2007; 28(6):865-70. PubMed ID: 17925657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe adverse cutaneous drug reactions to antiepileptic drugs: 18 years of experience in a tertiary referral dermatology clinic in Turkey.
    Özkaya E; Kılıç S
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e268-e270. PubMed ID: 29356180
    [No Abstract]   [Full Text] [Related]  

  • 36. T-cell activation in two cases of Stevens-Johnson syndrome after receiving amoxicillin-clavulanic acid.
    Mori F; Fili L; Barni S; Sarti L; Montemaggi A; Bassi A; Filippeschi C; Galli L; Parronchi P; Novembre E
    Pediatr Allergy Immunol; 2017 Sep; 28(6):602-606. PubMed ID: 28599076
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute renal failure associated with Stevens-Johnson syndrome - case study].
    Baranowski B; Jasiewicz-Honkisz B; Śliwa T
    Przegl Lek; 2016; 73(12):842-4. PubMed ID: 29693992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Toxic epidermal necrolysis (Lyell syndrome)].
    de Campos EC
    An Bras Dermatol; 1968; 43(1):25-39. PubMed ID: 5714129
    [No Abstract]   [Full Text] [Related]  

  • 39. [Etiology, pathogenesis, clinical picture and treatment of the Stevens-Johnson syndrome].
    Korolev IuF
    Vestn Dermatol Venerol; 1975 Nov; (11):23-5. PubMed ID: 1220373
    [No Abstract]   [Full Text] [Related]  

  • 40. [Stevens-Johnson syndrome secondary to carbamazepine mediated by photosensitivity].
    Suárez Moro R; Trapiella Martínez L; Avanzas González E; Salas Puig J; Fernández Fernández C
    An Med Interna; 2000 Feb; 17(2):105-6. PubMed ID: 10829471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.